{"transactions":[{"id":2296621,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-15T19:55:45.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":33000,"derivative":{"exercise_price":5.11,"expiration_date":"2032-04-13","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-22-046455","document":"tm2212851-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465922046455/tm2212851-8_4seq1.xml","form_type":"4"}},{"id":2738431,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-04-27T20:03:22.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":4,"value":80000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each CRH RSU represented a contingent right to receive one CRH share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All options to acquire CRH shares (\"CRH options\") and share units with respect to CRH shares (\"CRH RSUs\") outstanding immediately prior to the Effective Time were exchanged for either a cash payment equal to Share Consideration (less the applicable exercise price in respect of CRH options) or replacement options or restricted stock units with respect to WELL common shares, in accordance with the terms of the Arrangement Agreement and the plan of arrangement subject to the same vesting schedule as applied to the CRH RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Share Units expire on the earlier of June 30, 2021 or one day prior to the next Annual General Meeting of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-028733","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919121028733/doc4.xml","form_type":"4"}},{"id":2738430,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-27T20:03:22.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":4687,"price":3.52,"value":16498.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All options to acquire CRH shares (\"CRH options\") and share units with respect to CRH shares (\"CRH RSUs\") outstanding immediately prior to the Effective Time were exchanged for either a cash payment equal to Share Consideration (less the applicable exercise price in respect of CRH options) or replacement options or restricted stock units with respect to WELL common shares, in accordance with the terms of the Arrangement Agreement and the plan of arrangement subject to the same vesting schedule as applied to the CRH RSUs."}],"balance_after":0,"derivative":{"exercise_price":0.48,"expiration_date":"2023-12-12","underlying":"Common Shares","underlying_shares":4687},"source":{"system":"sec-edgar","filing":"0001209191-21-028733","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919121028733/doc4.xml","form_type":"4"}},{"id":2738429,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-04-27T20:03:22.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":495313,"price":4,"value":1981252.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to the Arrangement Agreement, dated as of February 6, 2021 (as amended, the \"Arrangement Agreement\"), by and among CRH Medical Corporation (\"CRH\"), WELL Health Technologies Corp. (\"WELL\"), WELL Health Acquisition Corp., a wholly owned subsidiary of WELL, and 1286392 B.C. Ltd, a wholly owned subsidiary of WELL, at 4:30 p.m. Eastern Time (the \"Effective Time\") on April 22, 2021 each common share of CRH (each, a \"CRH share\") issued and outstanding immediately before the Effective Time was transferred to a subsidiary of WELL, and the holders thereof became entitled to receive US$4.00 in cash, without interest and less any applicable withholding taxes (the \"Share Consideration\"), for each CRH share then held."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-028733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919121028733/doc4.xml","form_type":"4"}},{"id":2771089,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-26T23:35:03.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each of the first, second, third and fourth annual anniversaries of the date of grant."}],"balance_after":112000,"derivative":{"exercise_price":5.14,"expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001104659-21-042630","document":"tm2111079-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465921042630/tm2111079-3_4seq1.xml","form_type":"4"}},{"id":2952423,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T21:11:49.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":3.15,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001104659-20-133644","document":"tm2038059-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465920133644/tm2038059-11_4seq1.xml","form_type":"4"}},{"id":3110486,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit","published_at":"2020-06-15T20:10:01.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Share Units vest on or before expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Share Units will expire on the earlier of June 30, 2021 or one day prior to the next Annual General Meeting of the Issuer."}],"balance_after":20000,"derivative":{"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-036822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919120036822/doc4.xml","form_type":"4"}},{"id":3489506,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2019-06-14T20:47:25.000Z","date":"2019-06-12","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Share Units vest on or before expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2019-06-28","underlying":"Common Shares","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-19-037322","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919119037322/doc4.xml","form_type":"4"}},{"id":3489505,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-06-14T20:47:25.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 20,000 Common Shares to be issued upon settlement of 20,000 Restricted Share Units granted on June 13, 2019. The Restricted Share Units will expire on the earlier of June 30, 2020 or one day prior to the next Annual General Meeting of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."}],"balance_after":495313,"source":{"system":"sec-edgar","filing":"0001209191-19-037322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919119037322/doc4.xml","form_type":"4"}},{"id":3489504,"issuer":{"id":139998,"kind":"organization","name":"CRH Medical Corp","symbol":"CRHM"},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-06-14T20:47:25.000Z","date":"2019-06-12","kind":"exercise","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit represents the right to receive one Common Share upon settlement."}],"balance_after":475313,"source":{"system":"sec-edgar","filing":"0001209191-19-037322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461119/000120919119037322/doc4.xml","form_type":"4"}},{"id":3512534,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":128027,"kind":"person","name":"Patrick Todd","position":1,"cik":"0001762285","reported_name":"Patrick Todd","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-25T01:30:29.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":298724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each annual anniversary of the date of grant."}],"balance_after":298724,"derivative":{"exercise_price":3.15,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":298724},"source":{"system":"sec-edgar","filing":"0001144204-19-028259","document":"tv522365_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000114420419028259/tv522365_4.xml","form_type":"4"}}]}